Is remdesivir safe in patients with renal impairment? Experience at a large tertiary urban medical center

PURPOSE: Remdesivir is FDA-approved for treatment of patients hospitalized with COVID-19 pneumonia, but not recommended in patients with severe renal failure. This study aims to evaluate the safety of remdesivir in this patient population. METHODS: This was a single-center, retrospective cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunny, Subin, Samaroo-Campbell, Jevon, Abdallah, Marie, Luka, Alla, Quale, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132747/
https://www.ncbi.nlm.nih.gov/pubmed/35616879
http://dx.doi.org/10.1007/s15010-022-01850-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132747/
https://www.ncbi.nlm.nih.gov/pubmed/35616879
http://dx.doi.org/10.1007/s15010-022-01850-7

Ejemplares similares